NMLSF (Restart Life Sciences) E10: $-0.99 (As of Mar. 2026)


What is Restart Life Sciences E10?

Restart Life Sciences NMLSF E10 is $-0.99 as of Mar. 2026. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Restart Life Sciences's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.007. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.99 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Restart Life Sciences was 34.80% per year. The lowest was 24.90% per year. And the median was 29.85% per year.

As of today (2026-06-26), Restart Life Sciences's current stock price is $0.04912. Restart Life Sciences's E10 for the quarter that ended in Mar. 2026 was $-0.99. Restart Life Sciences's Shiller PE Ratio of today is .


Restart Life Sciences  (OTCPK:NMLSF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Restart Life Sciences E10 Related Terms


Restart Life Sciences E10 Historical Data

* Premium members only.

The historical data trend for Restart Life Sciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Restart Life Sciences E10 Chart

Restart Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -1.60 -1.35 -0.71 0.00

Restart Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.76 -1.01 -0.91 0.00 -0.99

NMLSF vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Restart Life Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Restart Life Sciences Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Restart Life Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Restart Life Sciences's Shiller PE Ratio falls into.



Restart Life Sciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Restart Life Sciences's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.007/132.2623*132.2623
=-0.007

Current CPI (Mar. 2026) = 132.2623.

Restart Life Sciences Quarterly Data

per share eps CPI Adj_EPS
201606 0.000 102.002 0.000
201609 0.000 101.765 0.000
201612 -0.900 101.449 -1.173
201703 -0.096 102.634 -0.124
201706 -0.119 103.029 -0.153
201709 -0.326 103.345 -0.417
201712 -0.313 103.345 -0.401
201803 -0.619 105.004 -0.780
201806 -0.051 105.557 -0.064
201809 -0.307 105.636 -0.384
201812 0.000 105.399 0.000
201903 -0.075 106.979 -0.093
201906 -0.075 107.690 -0.092
201909 -0.076 107.611 -0.093
201912 0.000 107.769 0.000
202003 -0.072 107.927 -0.088
202006 -1.402 108.401 -1.711
202009 -0.076 108.164 -0.093
202012 -1.269 108.559 -1.546
202103 -0.080 110.298 -0.096
202106 -0.031 111.720 -0.037
202109 -0.079 112.905 -0.093
202112 0.000 113.774 0.000
202203 -0.079 117.646 -0.089
202206 0.000 120.806 0.000
202209 -0.021 120.648 -0.023
202212 -0.074 120.964 -0.081
202303 -0.027 122.702 -0.029
202306 -0.015 124.203 -0.016
202309 -0.015 125.230 -0.016
202312 -0.015 125.072 -0.016
202403 -0.007 126.258 -0.007
202406 -0.007 127.522 -0.007
202409 0.022 127.285 0.023
202412 -0.007 127.364 -0.007
202503 -0.021 129.181 -0.022
202506 -0.007 129.892 -0.007
202509 -0.007 130.287 -0.007
202512 0.000 130.366 0.000
202603 -0.007 132.262 -0.007

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.99 mean?
Restart Life Sciences (NMLSF) has a E10 of $-0.99 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Restart Life Sciences and its competitors.
Is Restart Life Sciences' E10 too high?
Restart Life Sciences' current E10 is $-0.99.
How does Restart Life Sciences' E10 compare to VRTX and REGN?
Restart Life Sciences' E10 of $-0.99 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Restart Life Sciences and its competitors. Restart Life Sciences's current E10 is $-0.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Restart Life Sciences stock overvalued right now?
Restart Life Sciences (NMLSF) has a current E10 of $-0.99. The current E10 is $-0.99. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Restart Life Sciences (NMLSF), the current E10 is $-0.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Restart Life Sciences Business Description

Other Exchanges HEAL:Canada
Address 700 - 838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6
Restart Life Sciences Corp is a Canadian-based life sciences company dedicated to addressing health challenges with wellness solutions. Its brands include HolyCrap, BrainQ, Brain Balls.